Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1Breast 1

Conditions

Breast Neoplasms 1931Neoplasms 1385Carcinoma, Non-Small-Cell Lung 1324Prostatic Neoplasms 1070Multiple Myeloma 855Leukemia, Myeloid, Acute 759Neoplasm Metastasis 691Colorectal Neoplasms 676Melanoma 666Lung Neoplasms 665Lymphoma 655Leukemia 591Lymphoma, Non-Hodgkin 587Leukemia, Lymphocytic, Chronic, B-Cell 529Ovarian Neoplasms 517Pancreatic Neoplasms 493Precursor Cell Lymphoblastic Leukemia-Lymphoma 471Recurrence 466Myelodysplastic Syndromes 421Lymphoma, Follicular 407Head and Neck Neoplasms 401Glioblastoma 376Carcinoma, Renal Cell 375Lymphoma, Large B-Cell, Diffuse 372Brain Neoplasms 370Hodgkin Disease 352Carcinoma, Hepatocellular 324Squamous Cell Carcinoma of Head and Neck 323Lymphoma, Mantle-Cell 302Sarcoma 281

Interventions

Tamoxifen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Has results × Risk Reduction Behavior × Clear all
NCT03985852 2025-09-22

BRIDGE

University of Utah

Phase NA Completed
3,073 enrolled 7 charts

Neoplasms, Risk Reduction Behavior

NCT03346200 2025-03-07

KARISMA2

Karolinska Institutet

Phase 2 Completed
1,440 enrolled 14 charts
Breast

Breast Neoplasms, Risk Reduction Behavior

NCT03315286 2019-12-18

Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure

Weill Medical College of Cornell University

Phase NA Completed
111 enrolled 13 charts
Dermatologic

Skin Neoplasms, Health Behavior, Risk Reduction Behavior, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡